149 related articles for article (PubMed ID: 25551299)
1. NUT protein immunoreactivity in ovarian germ cell tumours.
Iacobelli JF; Charles AK; Crook M; Stewart CJ
Pathology; 2015 Feb; 47(2):118-22. PubMed ID: 25551299
[TBL] [Abstract][Full Text] [Related]
2. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding protein LIN28 is a sensitive marker of ovarian primitive germ cell tumours.
Xue D; Peng Y; Wang F; Allan RW; Cao D
Histopathology; 2011 Sep; 59(3):452-9. PubMed ID: 22034885
[TBL] [Abstract][Full Text] [Related]
4. Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours.
Saani I; Raj N; Sood R; Ansari S; Mandviwala HA; Sanchez E; Boussios S
Int J Environ Res Public Health; 2023 Jun; 20(12):. PubMed ID: 37372675
[TBL] [Abstract][Full Text] [Related]
5. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
6. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
Oz Atalay F; Aytac Vuruskan B; Vuruskan H
J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
[TBL] [Abstract][Full Text] [Related]
7. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
[TBL] [Abstract][Full Text] [Related]
8. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach.
Fichtner A; Richter A; Filmar S; Kircher S; Rosenwald A; Küffer S; Nettersheim D; Oing C; Marx A; Ströbel P; Bremmer F
Histopathology; 2022 Jan; 80(2):381-396. PubMed ID: 34506648
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary.
Trinh DT; Shibata K; Hirosawa T; Umezu T; Mizuno M; Kajiyama H; Kikkawa F
J Obstet Gynaecol Res; 2012 May; 38(5):841-8. PubMed ID: 22448662
[TBL] [Abstract][Full Text] [Related]
10. The utility of immunostaining for NUT, GAGE7 and NY-ESO-1 in the diagnosis of spermatocytic seminoma.
Kao CS; Badve SS; Ulbright TM
Histopathology; 2014 Jul; 65(1):35-44. PubMed ID: 24393139
[TBL] [Abstract][Full Text] [Related]
11. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
[TBL] [Abstract][Full Text] [Related]
12. Expression of glypican 3 in ovarian and extragonadal germ cell tumors.
Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ
Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091
[TBL] [Abstract][Full Text] [Related]
13. Germ Cell Tumors of the Female Genital Tract.
Euscher ED
Surg Pathol Clin; 2019 Jun; 12(2):621-649. PubMed ID: 31097117
[TBL] [Abstract][Full Text] [Related]
14. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract][Full Text] [Related]
15. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
[TBL] [Abstract][Full Text] [Related]
16. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features.
Shaaban AM; Rezvani M; Elsayes KM; Baskin H; Mourad A; Foster BR; Jarboe EA; Menias CO
Radiographics; 2014; 34(3):777-801. PubMed ID: 24819795
[TBL] [Abstract][Full Text] [Related]
17. Ovarian germ cell tumours: a 17-year study in a single unit.
Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of IMP3 between male and female mature teratomas--immunohistochemical evidence of malignant nature.
Goodman S; Zhang L; Cheng L; Jiang Z
Histopathology; 2014 Oct; 65(4):483-9. PubMed ID: 24605891
[TBL] [Abstract][Full Text] [Related]
19. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
Cao D; Li J; Guo CC; Allan RW; Humphrey PA
Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase II alpha expression in testicular germ cell tumors.
Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]